Gilead says critical study of Covid-19 drug shows patients are responding to treatment
(By Matthew Herper and Adam Feuerstein for STAT) A government-run study of Gilead’s remdesivir, perhaps the most closely watched experimental
Read More
Part D/Prescription Drugs
What you should know if you decide to enroll in Medicare
The COVID-19 pandemic is having a histrionic impact on employment in the United States and around the world. For those
Read More5 things to know about the Medicare appeals process
(Source – www.medicare.gov/blog) If you disagree with a coverage or payment decision made by your Medicare health or prescription drug
Read MoreViewpoint: What US must do to prevent widespread critical drug shortages
(By Maia Anderson for Becker’s Hospital Review) Widespread critical medication shortages will be the next big crisis of the COVID-19 pandemic,
Read MoreFDA warns against hydroxychloroquine use outside of hospital settings as prescriptions surge
(By Maia Anderson for Becker’s Hospita Review) The FDA issued a warning April 24 against using hydroxychloroquine outside of a hospital
Read MoreUnitedHealth to deploy 3,000 ventilators with Boston Scientific, Medtronic
(By Morgan Haefner for Becker’s Hospital Review) UnitedHealth Group is working with Boston Scientific, Medtronic and the University of Minnesota in
Read MorePandemic Underscores U.S. Dependence On Overseas Factories For Medicines
(By Syndey Lupkin for NPR) The coronavirus pandemic has renewed concerns about the dependence of the United States on other
Read MoreCoronavirus & Medicare enrollment: Get the coverage you need
(Source – www.medicare.gov/blog) To help stop the spread of the coronavirus disease 2019 (COVID-19), many businesses have temporarily closed. If
Read MoreCoronavirus Crisis Opens Access To Online Opioid Addiction Treatment
(By Phil Galewitz for Kaiser Health News) Opioid addiction isn’t taking a break during the coronavirus pandemic. But the U.S.
Read MoreImmunomedics wins FDA approval for new drug to treat aggressive form of breast cancer
(By Adam Feuerstein for STAT) Immunomedics secured U.S. approval on Wednesday for a new drug to treat women with a
Read More